Autologous Cord Blood Mononuclear Cells Modulate Immunity and the Microbiota in Very Preterm Twins: A Randomized Trial
- 28 April 2026
- journal article
- research article
- Published by Springer Nature in Stem Cell Reviews and Reports
- Vol. 22 (5) , 2511-2527
Abstract
No abstract availableKeywords
Funding Information
- Natural Science Foundation of Guangdong Province (2024A1515010299)
This publication has 49 references indexed in Scilit:
- Prevention for moderate or severe BPD with intravenous infusion of autologous cord blood mononuclear cells in very preterm infants-a prospective non-randomized placebo-controlled trial and two-year follow up outcomeseClinicalMedicine, 2023
- Principles of regulatory T cell functionImmunity, 2023
- A Placebo-controlled double-blinded test of the biodiversity hypothesis of immune-mediated diseases: Environmental microbial diversity elicits changes in cytokines and increase in T regulatory cells in young childrenEcotoxicology and Environmental Safety, 2022
- Aberrant gut-microbiota-immune-brain axis development in premature neonates with brain damageCell Host & Microbe, 2021
- Microbial exposure during early human development primes fetal immune cellsCell, 2021
- Stem Cells for Bronchopulmonary Dysplasia in Preterm Infants: A Randomized Controlled Phase II TrialStem Cells Translational Medicine, 2021
- Effects of mesenchymal stromal cells on regulatory T cells: Current understanding and clinical relevanceStem Cells, 2020
- Stereotypic Immune System Development in Newborn ChildrenCell, 2018
- Mesenchymal Stromal Cell Therapy in Bronchopulmonary Dysplasia: Systematic Review and Meta-Analysis of Preclinical StudiesStem Cells Translational Medicine, 2017
- Stem and progenitor cells in human umbilical cord bloodInternational Journal of Hematology, 2010